Basu A, Raghunath M, Bishayee S, Das M
Department of Biochemistry and Biophysics, Children's Hospital of Philadelphia, Pennsylvania.
Mol Cell Biol. 1989 Feb;9(2):671-7. doi: 10.1128/mcb.9.2.671-677.1989.
The tyrosine kinase activity of the epidermal growth factor (EGF) receptor is regulated by a truncated receptor of 100 kilodaltons (kDa) that contains the EGF-binding site but not the kinase domain. The inhibition of kinase is not due to competition for available EGF or for the kinase substrate-binding site. Chemical cross-linking studies suggest that the 100-kDa receptor may form a heterodimer with the intact EGF receptor. Structurally related receptor kinases, such as the platelet-derived growth factor receptor, the insulin receptor, and the Neu receptor, were not inhibited by the 100-kDa receptor. The results indicate that (i) the inhibition was specific for the EGF receptor, (ii) the kinase domain had little or no role in determining target specificity, and (iii) the regulation of kinase may be due to a specific interaction of the 100-kDa receptor with the ligand-binding domain of the EGF receptor kinase.
表皮生长因子(EGF)受体的酪氨酸激酶活性受一种100千道尔顿(kDa)的截短型受体调控,该受体含有EGF结合位点,但不包含激酶结构域。激酶的抑制并非由于对可用EGF或激酶底物结合位点的竞争。化学交联研究表明,100-kDa受体可能与完整的EGF受体形成异二聚体。结构相关的受体激酶,如血小板衍生生长因子受体、胰岛素受体和Neu受体,不受100-kDa受体的抑制。结果表明:(i)这种抑制对EGF受体具有特异性;(ii)激酶结构域在确定靶标特异性方面作用很小或没有作用;(iii)激酶的调控可能是由于100-kDa受体与EGF受体激酶的配体结合结构域之间的特异性相互作用。